Proton beam therapy is an advanced form of external radiotherapy that uses high-energy proton beams instead of photon x-ray beams or electrons. Carefully measured doses of protons are delivered to the precise area needing treatment, using the latest IBA ProteusONE technology. This ensures that the delivery of proton beam therapy is highly accurate and prevents the risk of radiation reaching surrounding healthy tissue.
Radiotherapy is used to kill and destroy cancer cells. It utilises radiation in the form of high-energy x-rays, known as photons, to kill and damage the cancerous cells and prevent their growth and reproduction. It can be used as a non-surgical option to treat cancer, and it can also be used to shrink a tumour or in combination with other treatments.
The Rutherford Cancer Centres and Elekta are bringing the next generation of personalised adaptive radiotherapy technology to oncology centres across the UK, with the new MR-linac Elekta Unity available at the Rutherford Cancer Centre North West in Liverpool from late 2020.
Professor Peter Barrett-Lee is a Consultant Clinical Oncologist, Professor of Oncology in the School of Medicine at Cardiff University and lead specialist in breast cancer and skin cancer at Velindre NHS Trust and the University of Wales.
Professor Peter Barrett-Lee was Medical Registrar at Mayday Hospital, Croydon and gained Membership of the Royal College of Physicians in 1985. He gained his Doctorate of Medicine Thesis in the laboratory of the Medical Breast unit at St George’s Hospital, London under the supervision of Professor R Charles Coombes. He trained for 5 years in both radiotherapy and medical oncology at the Royal Marsden Hospital and obtained the Fellowship of the Royal College of Radiologists. He then worked at the Meyerstein Institute of Clinical Oncology at UCL Hospitals London on several clinical trials of new hormones and chemotherapy that have now become standard treatments.
Find out more by visiting Professor Peter Barrett-Lees profile on: www.bupa.co.uk
Proton Beam Therapy
This consultant has received training from the Rutherford Cancer Centres in the delivery of proton beam therapy. The programme, Proton Therapy Clinical Education, in conjunction with The Perelman School of Medicine at the University of Pennsylvania and IBA, the leading proton beam therapy solutions manufacturer, involves oncologists gaining practical experience in Penn’s Roberts Proton Therapy Center – one of the world’s leading centres of proton therapy research and expertise.